Animal

Vetster Launches The Pet Friendly Workplace Certification

Retrieved on: 
Thursday, April 11, 2024
Veterinary, Telemedicine, Virtual Medicine, Human Resources, Pets, Health, Professional Services, Consumer, Business, Pet, Certification, HR, Animal, OnePoll, Workplace, Morale, Amazon, Culture, Exercise, Family, Mental health, Child, Millennials, DECIEM

Vetster, the leading pet health platform and global veterinary marketplace, today announced the launch of the Pet Friendly Workplace™ Certification, a new initiative aimed at recognizing pet-inclusive employers.

Key Points: 
  • Vetster, the leading pet health platform and global veterinary marketplace, today announced the launch of the Pet Friendly Workplace™ Certification, a new initiative aimed at recognizing pet-inclusive employers.
  • “The Pet Friendly Workplace™ Certification aims to recognize those companies already building programs to incorporate pets in the physical and virtual workplace, and help companies design programs that meet the needs of the modern employee.”
    Approximately 70% of households in North America have at least one pet and the demographic of those owners have changed significantly.
  • “By establishing clear policies and guidelines, I encourage other businesses to create a happy and productive work environment that embraces the presence of pets.”
    The Pet Friendly Workplace Certification is open to companies of all sizes who demonstrate a commitment to pet-inclusivity and are evaluated across four key areas:
    Pet Friendly Workplace Policies - Companies develop and incorporate pet policies throughout their people operations, including flex work strategies to accommodate pet care and exercise.
  • For more information about the Pet Friendly Workplace™ Certification and how to apply, visit petfriendly-workplace.com
    *According to a survey conducted by OnePoll on behalf of Vetster, 1800 employed pet owners.

OncoNano Medicine Presents Preclinical Data for ON-BOARD™ IL-12 Program at AACR Annual Meeting 2024

Retrieved on: 
Wednesday, April 10, 2024
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Mouse, Safety, IL-12, Gamma ray, Animal, Research and development, Plasma, Development, Observation, Therapy, Patient, Liver, Therapeutic index, AACR, NK

Despite its potent pleiotropic and well-established anti-cancer effects, the clinical application of IL-12 has been hindered by significant adverse toxicities.

Key Points: 
  • Despite its potent pleiotropic and well-established anti-cancer effects, the clinical application of IL-12 has been hindered by significant adverse toxicities.
  • OncoNano developed ON-BOARD™, an ultra-pH sensitive nanoparticle platform, to shield payloads from systemic exposure and target solid tumors by responding to the highly acidic tumor microenvironment.
  • Findings also reveal that ONM-412 illustrates favorable stability and pH-responsive IL-12 bioactivity in vitro,” said Tian Zhao, Ph.D., Vice President of Research and Development for OncoNano Medicine.
  • Link to the poster may be found on the OncoNano Medicine website at: News - OncoNano Medicine .

Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies and Better Predict Human Outcomes for Age-Related Diseases

Retrieved on: 
Friday, April 26, 2024
Founders Fund, FDA, OA, Patient, Horse, Cell, Notifiable disease, Animal, OARSI, Osteoarthritis Research Society International, Infection, Entrepreneurship, Research, Pathology, Artificial intelligence, Disease, Human, Novartis, Therapy, Ageing, Pulmonary fibrosis, Osteoarthritis, Gene, Biology, Drug discovery, Longevity, World Congress, MASH, Heart failure, Pharmaceutical industry

SAN FRANCISCO, April 26, 2024 /PRNewswire/ -- Gordian Biotechnology, an in vivo drug discovery and development company, today announced its platform that enables patient predictive, in vivo screening of hundreds of gene targets for FDA-recognized diseases of aging at a scale never before possible.

Key Points: 
  • Gordian's Osteoarthritis (OA) program has screened hundreds of therapies in horses that acquired OA naturally and advanced dozens of therapies into human ex vivo validation studies.
  • In proof of concept experiments during initial development, Gordian introduced a pooled library of 50 gene therapies into a mouse model of metabolic-associated steatohepatitis (MASH).
  • The therapies were evaluated using the company's proprietary in vivo screening platform, which successfully recapitulated 13 out of 16 clinical outcomes for targets where clinical data exists.
  • Mosaic Screening™ is pooled in vivo screening that tests hundreds of therapies simultaneously in a single sick animal, the Patient Avatar.

Hike Doggie is Blazing New Trails: Welcoming Our First Franchise - Hike Doggie Denver South!

Retrieved on: 
Thursday, April 25, 2024
Health, Hike, Dog, Animal, Nature, Parent, Happiness

Barrett is a passionate advocate for the well-being of animals, an outdoor enthusiast, and a former Hike Doggie hiker!

Key Points: 
  • Barrett is a passionate advocate for the well-being of animals, an outdoor enthusiast, and a former Hike Doggie hiker!
  • Denver South is loaded with countless scenic trails, dog-friendly spaces, and lots of dogs drooling for fun; making it the perfect location for Hike Doggie outings.
  • Kath Allen, the founder of Hike Doggie, is on fire with enthusiasm about the expansion and opportunity for others to franchise: "Welcoming Barrett and launching the Denver South location is beyond exciting for Hike Doggie.
  • To celebrate the Denver South launch, Hike Doggie is hosting a series of welcome hikes and community events.

GENESIS AND THE GENESIS INSPIRATION FOUNDATION SUPPORT STEAM EDUCATION AT GENESIS OF CENTRAL FLORIDA GRAND OPENING

Retrieved on: 
Thursday, April 25, 2024
Education, G70, EVS, Seed, Safety, Genesis GV70, Animal, Price action trading, GV70, Water, Carbon, Plant, STEM, Curriculum, Engineering, Mathematics, Genesis G80, Multimedia, Everglades Foundation, Student, Boy, Electrification, Longevity, Video game

The Everglades Foundation received $10,000 from Genesis Gives and the Boys & Girls Clubs of Central Florida received $10,000 from the Genesis Inspiration Foundation.

Key Points: 
  • The Everglades Foundation received $10,000 from Genesis Gives and the Boys & Girls Clubs of Central Florida received $10,000 from the Genesis Inspiration Foundation.
  • "Genesis and the Genesis Inspiration Foundation are proud to invest in STEAM education for youth in the local community as we celebrate the grand opening of Genesis of Central Florida."
  • The Boys & Girls Clubs of Central Florida includes 40 Clubs in six counties throughout Central Florida.
  • Genesis of Central Florida is one of many planned standalone retail facilities for the brand in the United States.

Upholding their Oath: Veterinarians Balance Purpose with Practicality

Retrieved on: 
Thursday, April 25, 2024
Veterinarian, Cancer, Heart, Pet, Hospital, Research, Animal, AVMF, Love, Veterinary medicine, REACH, Hardship, DVM, Family, CVT, Patient, Fatigue, Face, Calendar

ST. LOUIS, April 25, 2024 /PRNewswire/ -- From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that commitment increasingly difficult. Long hours, understaffing, student debt and fatigue can all take their toll – but nothing more so than clients who can't afford appropriate veterinary care, according to a survey conducted by Purina Pro Plan Veterinary Diets ahead of World Veterinary Day, which is celebrated the last Saturday of April.

Key Points: 
  • In the survey*, nearly 6 in 10 practitioners (57%) said their desire to become veterinarians began in elementary school or earlier, fueled by a shared aspiration to make pets' lives better.
  • All such solutions require sacrifice on the part of veterinarians, whether the cost is emotional, financial or professional, noted Dr. Harris.
  • Veterinarians can visit www.ProPlanVetSupport.com to learn more about the Pro Plan Veterinary Support Mission and to see if they qualify for a grant under the AVMF REACH Program.
  • A total of 301 U.S. companion animal and mixed animal veterinarians working 20 or more hours per week qualified and completed the survey.

ACTS LAW Addresses Federal Correctional Institution in Dublin Controversy

Retrieved on: 
Wednesday, April 24, 2024
Crime, Woman, Prison, Animal, Rehabilitation, Male, Minor, ACTS, Female, Paraphilia, Assault, County, Behavior, Superior court, Sacramento County Superior Court

Recently, the Federal Correctional Institution in Dublin is facing closure over allegations of similar types of behavior, with matters so bad it was known as a "rape club" by inmates and workers.

Key Points: 
  • Recently, the Federal Correctional Institution in Dublin is facing closure over allegations of similar types of behavior, with matters so bad it was known as a "rape club" by inmates and workers.
  • "The racial and class inequity that leads to women being imprisoned has never been addressed in our state," Mr. Rochen said.
  • "In the FCI Dublin institution, inmates were subjected to all manner of horrific sexual crimes on a daily basis.
  • He was the supervisor of the call center operated by the federal prison, where these women worked.

Berman and Company Takes Home Eight New Awards, Including a 40 Under 40 Award and Best in Show

Retrieved on: 
Wednesday, April 24, 2024
Best in Show, Management consulting, Center for Union Facts, United, Animal, AAPC, Hoarding, Humane society, Butter, Society, Television, Berman, Gold, Environment, Berman and Company, Marketing, Advertising, Bread, Organization

ROSSLYN, Va., April 24, 2024 /PRNewswire/ -- Berman and Company, a cutting-edge full-service public relations firm, announced eight award wins for the firm's issue advocacy work in 2023. These wins include:

Key Points: 
  • These wins include:
    An American Association of Political Consultants (AAPC) 40 under 40 win, awarded to Berman owner and partner Jack Hubbard.
  • The high-profile campaign successfully educated Californians on a union-backed ballot measure that would have forced hotels to house homeless individuals.
  • The Homeless Hotel campaign won Bronze for "Best in Show" and Gold for best local television spot.
  • Berman and Company has received more than 100 national awards for creative and conversation-starting work.

FDA Approves New Treatment for Uncomplicated Urinary Tract Infections

Retrieved on: 
Wednesday, April 24, 2024
Urine, UTI, FDA, Public, Patient, Staphylococcus, Urinary tract infection, Pivmecillinam, Priority review, Safety, Woman, Cosmetics, Food, Dietary supplement, Heated tobacco product, Infection, Research, Human services, Bacteria, Nausea, Staphylococcus saprophyticus, Escherichia coli, Porphyria, Vaccine, History, Female, Therapy, System, Tablet, Diarrhea, Hypersensitivity, Multimedia, Animal, Proteus mirabilis, Clinical trial, Metabolic disorder, Division, Ibuprofen

SILVER SPRING, Md., April 24, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.

Key Points: 
  • SILVER SPRING, Md., April 24, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.
  • "The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will provide an additional treatment option for uncomplicated UTIs."
  • Uncomplicated UTIs are bacterial infections of the bladder in females with no structural abnormalities of their urinary tract.
  • Approximately one-half of all women experience at least one UTI in their lifetime.

VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services

Retrieved on: 
Wednesday, April 24, 2024
Bleeding, Pet, Health, Animal, Anesthesia, Patient, Standard of care, Neoplasm, Veterinary medicine

NEW YORK, April 24, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of veterinary products and services in the U.S., including Midwest Veterinary Supply, Victor Medical Company, and Penn Veterinary Supply.

Key Points: 
  • Cresilon's VETIGEL – a revolutionary plant-based hemostatic gel that instantly stops and controls bleeding – is now available for veterinary surgeons to purchase directly through Midwest Veterinary Supply , Victor Medical Company , and Penn Veterinary Supply .
  • Additionally, VETIGEL is available through national distributors (as previously announced ).
  • For a list of all current distributors, visit Buy VETIGEL U.S. – VETIGEL Hemostatic Gel .
  • In addition to Midwest Veterinary Supply, Victor Medical Company, and Penn Veterinary Supply, VETIGEL is also available through several other leading animal health and veterinary product suppliers in the U.S., including Covetrus, MWI Animal Health, and Patterson Veterinary Supply.